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Abstract
Background: Hip fracture causes moderate to severe pain and while fascia iliaca block has been reported to
provide analgesic benefit, most previous trials were unblinded, with subsequent high risks of performance, selection
and detection biases. In this randomized, control double-blind trial, we tested the hypothesis that a fascia iliaca
block provides effective analgesia for patients suffering from hip fracture.
Methods: Thirty ASA I-III hip fracture patients over 70 years old, who received prehospital morphine, were
randomized to receive either a fascia iliaca block using 30 ml of bupivacaine 0.5% with epinephrine 1:200,000 or a
sham injection with normal saline. The fascia iliaca block was administered by emergency medicine physicians
trained to perform an anatomic landmark-based technique. The primary outcome was the comparison between
groups of the longitudinal pain score profiles at rest over the first 45 min following the procedure (numeric rating
scale, 0–10). Secondary outcomes included the longitudinal pain score profiles on movement and the comparison
over 4 h, 8 h, 12 h, and 24 h after the procedure, along with cumulative intravenous morphine consumption at 24 h.
Results: At baseline, the fascia iliaca group had a lower mean pain score than the sham injection group, both at
rest (difference = − 0.9, 95%CI [− 2.4, 0.5]) and on movement (difference = − 0.9, 95%CI [− 2.7; 0.9]). These differences
remained 45 min after the procedure and the two longitudinal pain score profiles were parallel both for patients at
rest and on movement (test of parallelism for patients at rest p = 0.53 and on movement p = 0.45). The same
parallel change in pain scores over time was observed over 24 h of follow-up (test of parallelism for patients at rest
p = 0.82 and on movement p = 0.12). These results were confirmed after adjustment for gender, ASA score, and
cumulative sums of intravenous morphine received pre-procedure and during-follow-up. In addition, there was no
difference between the two groups in total cumulative intravenous morphine consumption at 24 h.
Conclusion: Fascia iliaca block following anatomic landmarks may not provide supplementary analgesia for
patients suffering from hip fracture, when low pain scores are reported after prehospital morphine. Additional larger
trials will help reach definitive conclusion.
Trial registration number: Clinicaltrials.gov – NCT02433548. The study was registered retrospectively.
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Background
Hip fracture is very common in the elderly, with an inci-
dence of 4.6 per 1000 adults over 50 years old [1], and ac-
counts for as many as 8.9 per 1000 emergency department
visits [2]. Hip fracture causes moderate to severe pain, but
pain management has often been reported as insufficient
[2]. Under-treatment of acute pain in emergency medicine
may affect over 40% of patients in both prehospital and
in-hospital settings, and extends to the pain management
of hip fracture [3–5]. Inadequate pain management re-
sults from several factors, including underestimation of
pain intensity by healthcare providers, insufficient ad-
ministration of analgesics due to the fear of side-effects
or under-estimation of the doses required to treat mod-
erate to severe pain [6]. Unfortunately, unrelieved pain
increases the risk of delirium among patients suffering
from hip fracture by a factor of nine [7], and has
prompted investigation of alternative pain treatments,
such as regional anaesthetic techniques [8].
The hip joint is innervated by the femoral and obtur-
ator nerves anteriorly, and the sciatic nerve posteriorly
[9]. The fascia iliaca block (FIB) was first described in
1989 and consists of injecting local anaesthetics below
the fascia iliaca and lateral to the femoral vessels, pur-
portedly resulting in anaesthesia of the lateral cutaneous,
femoral and obturator nerves [10]. Since then, FIB has
been reported to provide adequate analgesia in hip frac-
ture case series [11, 12]. It has also been stated that FIB
can be easily performed by non-anaesthesiologists, given
the very low risk of complications [11, 13]. Despite these
reports, evidence suggests that less than one third of
physicians in emergency departments perform this re-
gional block [14], due mainly to a lack of supporting evi-
dence [15]. Although a recent meta-analysis concluded
that this technique provides analgesic benefit [16], the
conclusion is limited by the absence of blinding in 6 out
of 8 included articles, with subsequent high risks of per-
formance, selection and detection biases [8, 17–21]. The
two remaining articles arguably overstated their conclu-
sions [22, 23], as a significant difference was present at
only a single time interval. The magnitude of analgesic
efficacy of FIB for patients suffering from hip fracture
therefore remains unanswered.
In this randomized, controlled double-blind trial, we
tested the hypothesis that landmark-based FIB for hip
fracture, performed by emergency medicine physicians,
provides effective analgesia.
Methods
Ethical approval was granted by the ethics committee of
the Lausanne University Hospital, Switzerland (Commis-
sion cantonale d’éthique de la recherche sur l’être humain,
study ID number: 318/14) on October 10, 2014, and the
trial was registered on Clinicaltrials.gov (NCT02433548)
on October 20, 2014. The CONSORT statement was
followed in reporting this trial [24]. The study took place
in the Emergency department of the Lausanne University
Hospital between November 7, 2014 and June 2, 2016.
Study participation was proposed to patients over 70 years
old who were admitted for to the emergency department
with fractured hip. Exclusion criteria were bleeding dis-
order or presence of anticoagulation, periprosthetic frac-
ture, a known polyneuropathy, body weight below 40 kg,
chronic pain condition, patients undergoing chemother-
apy, infection at the site of injection, allergy to local anaes-
thetics and cognitive disorder.
After written informed consent was obtained, subjects
were randomly allocated to either the experimental
group (FIB group) or the control group (sham injection
group) according to a computer-generated list of ran-
dom numbers (www.randomization.com, seed 20,388).
Assignments were concealed in a sealed opaque enve-
lope. An emergency medicine physician, who was not re-
sponsible for the patient’s care, prepared the study drugs
in syringes and performed the block procedure. A
blinded study nurse collected the data. The physicians
and nurses responsible for the patient’s care in the emer-
gency department and on the ward were all blinded to
the group allocation.
All procedures were performed in the emergency de-
partment, by emergency medicine physicians. Electrocar-
diogram, pulse oximetry, and blood pressure monitors
were routinely applied. Oxygen was provided and per-
ipheral intravenous access was established. Patients in
the FIB group received an injection of 30 ml bupivacaine
0.5% with epinephrine 1:200,000, following an anatom-
ical landmark-based technique previously described [10,
25]. Briefly, the site of injection was identified and
marked 1 cm below the junction of the lateral and mid-
dle thirds of a line between the anterior superior iliac
spine and the pubic tubercle. After sterilization with a
solution of chlorhexidine 2% in isopropyl alcohol 70%, a
short-bevel needle (Plexifix® 50 mm, 24 G, BBraun med-
ical AG, Melsungen, Germany) was inserted at a right
angle to the skin until 2 losses of resistance were felt,
corresponding to the fascia lata and fascia iliaca piercing,
respectively. The entire volume was then injected in 5
ml-increments. Patients assigned to the control group
received a 5 ml-subcutaneous injection of normal saline
in the same location after sterilization of the skin. All
procedures were performed by physicians who had ex-
perience with the anatomical landmark-based technique
and who were not further involved in the study.
After the procedure, patients received acetamino-
phen 1000 mg every 6 h. Persistent pain (numeric rat-
ing scale [NRS] > 3) was treated with intravenous
morphine as needed. After transfer to the orthopaedic
ward, patients were prescribed acetaminophen 1000
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mg every 6 h and subcutaneous morphine 0.1 mg.kg− 1
every 6 h as needed.
We originally planned to compare the two mean pain
scores (fascia iliaca block versus sham injection groups)
at 45 min. However, given that, despite randomisation,
the two groups had different mean baseline scores, we
elected to evaluate the longitudinal pain trajectories and
tested for parallelism instead. Therefore, the primary
outcome was the comparison between groups of the lon-
gitudinal pain score profiles at rest over the first 45 min
following the procedure. Pain intensity was assessed with
an 11-point numeric rating scale (NRS), ranging from 0
(no pain) to 10 (worst imaginable pain). Secondary pain-
related outcomes included comparison of the longitu-
dinal pain score profiles on movement over the first 45
min following the procedure; longitudinal pain score
profiles at rest and during movement (standardized






Gender (male / female) 3 / 12 6 / 9
Age (years) 78 (73–90) 83 (73–90)
Height (cm) 165 (162–173) 170 (160–180)
Weight (kg) 65 (58–80) 63 (50–74)
ASA (I / II / III) 4 / 11 / 0 2 / 12 / 1
Pre-procedure analgesic data
Pain at rest (NRS, 0–10) 2 (1–4) 2 (2–5)
Pain on movement (NRS, 0–10) 7 (5–9) 8 (6–10)
Intravenous morphine
consumption (mg)
7 (2–10) 4 (0–14)
ASA American Society of Anaesthesiologists, NRS Numeric Rating Scale
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gentle 15°-elevation of the leg) 4 h, 8 h, 12 h and 24 h
after the injection (NRS, 0–10); and cumulative intraven-
ous morphine consumption at 24 h after the injection
(mg). Other outcomes were length of stay, and mortality
at 3 months. The between group difference in NRS score
over time was analysed as a post hoc addition to the
protocol in order to explore the potential impact of
baseline pain score differences between groups.
Based on published data, mean NRS pain score at rest
when patients are untreated was anticipated to be 8/10
with a variance of 2 [18]. We determined a clinically
meaningful decrease in pain score at rest to be 2 points
after a fascia iliaca block. As a result, we calculated that
a minimum of 10 patients per group was necessary to
detect a difference between groups, with a power of 90%
and an alpha error of 0.05, using a one-sided test. Allow-
ing for a 50% patient drop-out rate due to protocol vio-
lation or consent withdrawal, we planned to enrol a total
of 30 patients. Continuous and non-continuous data are
summarized as medians with 25th–75th interquartile
ranges (IQR), means and standard deviations or absolute
numbers, when appropriate. Baseline characteristics of
the two groups were compared using the Wilcoxon-
Mann-Whitney rank sum test for continuous variables
(age, pre-intervention drug dose received) and by the
Pearson’s chi-squared test for discrete variables (gender,
ASA score, etc.). The NRS over time was analysed using
linear mixed models with a random effect to account for
the correlation induced by the individual differences
[26]. The analyses were adjusted for gender, ASA
score, and pre-procedure intravenous morphine con-
sumption. The between group difference in NRS was
assessed over time for different follow-up periods
using the Wald test. The interaction between gender
and ASA category was also tested. The best dose-
response functional forms for the pre-intervention cu-
mulative intravenous morphine consumption were
assessed by the method of fractional polynomials and
the goodness of fit by residual analysis [27]. Signifi-
cance was considered at p < 0.05. Statistical analyses
were performed using the Stata 14.2 statistical pack-
age (Stata Corporation, College Station, Texas).
Fig. 2 Individual evolution of pain scores at rest 45 min after the procedure
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Results
Thirty patients were recruited, and all completed the
follow-up for the primary outcome. Figure 1 presents
the flow of patients through the trial, and Table 1 de-
scribes the patient characteristics.
At baseline (before the injection) the mean pain score at
rest was lower in the FIB group (FIB group: 2.3, 95%CI
[1.2, 3.3]; Sham injection group: 3.2, 95%CI [2.2, 4.2]; dif-
ference: -0.9, 95%CI [− 2.4, 0.5]). The difference between
groups remained unchanged 45min after the injection
(FIB group: 1.3, 95%CI [0.3, 2.3]; Sham injection group:
2.8, 95%CI [1.7, 3.8]; difference: -1.5, 95%CI [− 2.9, 0.0];
test of equality of the two differences (i.e. parallelism): p =
0.53, Fig. 2). Similarly, the between group difference in
mean pain scores on movement was also unchanged from
baseline to 45min after the procedure (baseline difference:
-0.9, 95%CI [− 2.7; 0.9]; difference at 45min: -1.6, 95%CI
[− 3.4; 0.2]; test of equality of the two differences (i.e. par-
allelism): p = 0.45; Fig. 3). This equality of the two differ-
ences (i.e. the parallelism) persisted after adjustment for
gender, ASA score, and pre-procedure intravenous
morphine consumption (p = 0.50 for the test of equality of
the two differences (i.e. parallelism) at rest and p = 0.45 on
movement). Likewise, analyses over the periods of 4 h, 8 h,
12 h and 24 h after the procedure showed parallelism in
the longitudinal pain scores at rest (p = 0.82; Fig. 4) and
on movement (p = 0.12; Fig. 5), after adjustment for the
same co-variables (p = 0.80 and p = 0.11, respectively).
Over the 24-h follow-up period, cumulative intraven-
ous morphine consumption was similar between groups
(FIB group: 7 mg, IQR [2; 15]; Sham injection group: 8
mg, IQR [6; 12]; p = 0.63), despite an apparent higher
pre-procedure dose for the FIB group (FIB group: 7 mg,
IQR [2; 10]; Sham injection group: 4 mg, IQR [0; 14];
p = 0.57), and an apparent lower cumulative dose
during-follow-up (FIB group: 0 mg, IQR [0; 7.5], Sham
injection group: 2 mg, IQR [0; 7]; p = 0.71).
Finally, the fascia iliaca block did not impact on the
length of stay (FIB group: 8 days, IQR [7; 11]; Sham in-
jection group: 9 days, IQR [7; 12]; p = 0.60). Three pa-
tients in the FIB group, and one in the sham injection
group died at 3 months (p = 0.28).
Fig. 3 Individual evolution of pain scores on movement 45 min after the procedure
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Discussion
This randomized-controlled trial suggests that anatomic
landmark-based FIB does not provide additional anal-
gesia benefit for patients in the emergency department
suffering from hip fracture. While previous double-
blinded investigations concluded that FIB reduces pain
scores at 15 min [23] and 3 h after the procedure [22],
when compared to non-steroidal inflammatory drugs or
intramuscular morphine, respectively, we were unable to
reproduce these results. Several factors may explain the
differences seen in the present trial.
First, the reduction in pain scores in these two reports
was not consistent through the timeline, as authors
found a difference only at a single time interval and only
for one modality of pain score [22, 23]. Second, and
more importantly, we did not exclude patients who re-
ceived prehospital opioids and therefore the baseline
pain scores of our population were found to be much
lower than those reported in the literature. Indeed, in
our setting, the median pre-procedure pain score at rest
was 2 (mean 3.2), while other authors have described a
median of 8 [22, 23]. Of note, despite randomisation, pa-
tients in the FIB group reported a lower baseline pain
score than those in the Sham injection group both at
rest and on movement. This difference was explained by
a higher pre-procedure morphine consumption in the
FIB group. As a result, in the multivariable analyses we
adjusted for both pre-procedure and post-intervention
morphine consumption, in addition to ASA group and
gender. Both adjusted and unadjusted analyses confirm
the parallel longitudinal pain profile of the two groups,
reinforcing the conclusion that FIB may not offer a sig-
nificant supplementary analgesic benefit when patients
report low pain scores after receiving prehospital mor-
phine. We therefore believe that our methodology
echoes the daily practice of emergency departments and
reflects effectiveness of the intervention in the real-
world environment.
There are several limitations associated with the
present study. First, we did not assess the sensory onset
of our blocks. This was omitted specifically to help
maintain blinding of the group allocations. We were
Fig. 4 Longitudinal evolution of pain scores at rest between groups. FIB, fascia iliaca block; NRS, Numeric Rating Scale
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therefore unable to quantify a block success rate. How-
ever, all blocks were performed by emergency medicine
physicians who routinely used the described procedure
in daily clinical practice. Further, we recruited a total of
30 patients for the comparison of two independent
means in line with our sample size calculation. However,
as explained in the method section, despite randomisa-
tion, the mean baseline scores were significantly differ-
ent between groups. We therefore decided to evaluate
the longitudinal pain score trajectories and test for par-
allelism rather than a simple comparison of means. This
approach, caries greater statistical power than the com-
parison of two means (as it is based on longitudinal
data). Nevertheless, the original sample size calculation
did not factor in this design and the risk of a type II error
cannot be excluded. Although we adjusted for baseline
characteristics such as gender, ASA score and pre-
procedure intravenous morphine consumption, there may
have been other unmeasured baseline characteristics,
which should have been adjusted for. Our data should
therefore be considered as preliminary and we suggest
further research would add additional value. Finally, the
choice of an anatomic landmark-based approach makes
extrapolation of the study results to ultrasound-guided
techniques uncertain. There is some evidence that incorp-
oration of ultrasound may have a positive impact on the
sensory blockade territory [28] and therefore may produce
a different clinical outcome than our results. Future inves-
tigation into the analgesic efficacy of ultrasound-guided
block, especially in light of new approaches of the lumbar
plexus [29] would be beneficial.
Conclusions
In conclusion, fascia iliaca block following anatomic land-
marks may not provide supplementary analgesia for pa-
tients suffering from hip fracture, when low pain scores
are reported after prehospital morphine. Additional larger
trials will help reach more definitive conclusions.
Abbreviations
95%CI: 95% confidence interval; ASA: American Society of Anesthesiologists;
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Fig. 5 Longitudinal evolution of pain scores on movement between groups. FIB, fascia iliaca block; NRS, Numeric Rating Scale
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